G2 and S phase‐expressed‐1 induces chromosomal instability in esophageal squamous cell carcinoma cells and inhibits cell apoptosis through ROS/JNK signaling

New diagnostic and therapeutic strategies are urgently needed to improve the prognosis of patients with esophageal squamous cell carcinoma (ESCC), which has high morbidity and mortality. Bioinformatics analysis revealed that cell cycle regulation related molecular G2 and S phase‐expressed‐1 (GTSE1) was dysregulated in ESCC. In this study, the ectopic expression of GTSE1 was verified in ESCC patients' tissues and cell lines. After overexpression or knockdown of GTSE1 using lentiviral transfection, the effects of GTSE1 on the proliferation, migration, invasion, and apoptosis of ESCC cells were detected. The contribution of GTSE1 in inducing chromosomal missegregation in cells leading to chromosome instability (CIN) has been described. Long‐term existence of CIN can increase reactive oxygen species (ROS) generation in ESCC cells, followed by inhibition of apoptosis by activating the c‐Jun N‐terminal kinase (JNK) signaling pathway, and this inhibition could be relieved after treatment with JNK inhibitor. In vivo experiments, we also confirmed the tumor‐promoting effect and mechanism of GTSE1 in ESCC using nude mice model. In this study, we demonstrated that GTSE1 induces CIN in ESCC cells, and increases intracellular ROS production, which leads to cellular oxidative stress, contributes to the activation of the JNK signaling pathway, and thereby inhibits apoptosis leading to ESCC tumorigenesis.

[1]  M. Milán,et al.  Proteostasis failure and mitochondrial dysfunction leads to aneuploidy-induced senescence. , 2021, Developmental cell.

[2]  Lu-Biao Chen,et al.  GTSE1 promotes SNAIL1 degradation by facilitating its nuclear export in hepatocellular carcin oma cells , 2021, Molecular medicine reports.

[3]  A. Bird,et al.  Destabilization of Long Astral Microtubules via Cdk1-Dependent Removal of GTSE1 from Their Plus Ends Facilitates Prometaphase Spindle Orientation , 2020, Current Biology.

[4]  X. Wen,et al.  GTSE1 promotes prostate cancer cell proliferation via the SP1/FOXM1 signaling pathway , 2020, Laboratory Investigation.

[5]  K. Zhao,et al.  The epigenetic basis of cellular heterogeneity , 2020, Nature Reviews Genetics.

[6]  V. Villegas,et al.  Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines , 2020, Cancer biology & medicine.

[7]  Mitchell L. Leibowitz,et al.  Small but mighty: the causes and consequences of micronucleus rupture , 2020, Experimental & Molecular Medicine.

[8]  H. Morreau,et al.  Metabolic reprogramming related to whole-chromosome instability in models for Hürthle cell carcinoma , 2020, Scientific Reports.

[9]  Bi-Jun Huang,et al.  GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner , 2019, Journal of experimental & clinical cancer research : CR.

[10]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[11]  Xia Li,et al.  Ginkgolide K protects SH-SY5Y cells against oxygen-glucose deprivation-induced injury by inhibiting the p38 and JNK signaling pathways , 2018, Molecular medicine reports.

[12]  Samuel F. Bakhoum,et al.  Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.

[13]  T. Cotter,et al.  Seminars in Cell & Developmental Biology , 2018 .

[14]  A. Bird,et al.  GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK , 2016, The Journal of cell biology.

[15]  B. Short GTSE1 leads cancer cells into CIN , 2016, The Journal of cell biology.

[16]  T. Mak,et al.  TNF and ROS Crosstalk in Inflammation. , 2016, Trends in cell biology.

[17]  A. Nebreda,et al.  Gene Dosage Imbalance Contributes to Chromosomal Instability-Induced Tumorigenesis. , 2016, Developmental cell.

[18]  W. Yong,et al.  GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells , 2015, BMC Cancer.

[19]  J. Ferlay,et al.  Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.

[20]  Jianbin Wang,et al.  JNK signaling is needed to tolerate chromosomal instability , 2014, Cell cycle.

[21]  Jiri Bartek,et al.  Replication stress links structural and numerical cancer chromosomal instability , 2013, Nature.

[22]  A. Hyman,et al.  GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration , 2012, PloS one.

[23]  Yves Pommier,et al.  γH2AX and cancer , 2008, Nature Reviews Cancer.

[24]  Duane A. Compton,et al.  Examining the link between chromosomal instability and aneuploidy in human cells , 2008, The Journal of cell biology.

[25]  Jing-Yuan Fang,et al.  The MAPK signalling pathways and colorectal cancer. , 2005, The Lancet. Oncology.

[26]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[27]  E. Elton Esophageal cancer. , 2005, Disease-a-month : DM.

[28]  P. Sandy,et al.  The Cell Cycle-regulated Protein Human GTSE-1 Controls DNA Damage-induced Apoptosis by Affecting p53 Function* , 2003, Journal of Biological Chemistry.

[29]  R. Verardo,et al.  Cell‐cycle regulation of the p53‐inducible gene B99 , 2000, FEBS letters.

[30]  D. Lazarević,et al.  Cloning, chromosome mapping and functional characterization of a human homologue of murine gtse-1 (B99) gene. , 2000, Gene.

[31]  D. Lazarević,et al.  A novel p53‐inducible gene coding for a microtubule‐localized protein with G2‐phase‐specific expression , 1998, The EMBO journal.